O-1918

A selective antagonist of abnormal cannabidiol-mediated effects

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
1mg

￥500.00

400.00

- +
5mg

￥1912.00

1530.00

- +
10mg

￥2862.00

2290.00

- +
25mg

￥5325.00

4260.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci11936
CAS: 536697-79-7
别名: 1,3-二甲氧基-5-甲基-2-[(1R,6R)-3-甲基-6-(1-甲基乙烯基)-2-环己烯-1-基]苯
分子式: C19H26O2
分子量: 286.41
纯度: >98%
溶解度: 30mg/mL in ethanol, or in DMSO, or in DMF
储存: Store at -20°C
库存: 现货

Background

Abnormal cannabidiol is a synthetic regioisomer of cannabidiol that fails to elicit either central cannabinoid (CB1) or peripheral cannabinoid (CB2) responsiveness and is without psychotropic activity. It induces endothelium-dependent vasodilation via a CB1/CB2/nitric oxide-independent mechanism. O-1918 is a cannabidiol analog that acts as a selective antagonist of abnormal cannabidiol at the non-CB1/CB2 endothelial receptor. It does not bind to CB1 or CB2 receptors at concentrations up to 30 μM and inhibits the vasorelaxant effects of abnormal cannabidiol in vitro and in whole animals.1 It also blocks the abnormal cannabidiol-induced activation of the phosphatidylinositol 3-kinase/Akt pathway in human umbilical vein endothelial cells.[1] Reference:
[1]. Offertáler, L., Mo, F.M., Bátkai, S., et al. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Molecular Pharmacology 63(3), 699-705 (2003).